Takeda Pharmaceuticals’ Dexilant SoluTab delayed-release orally disintegrating tablets received FDA approval. 1. The tablets are a new formulation of dexlansoprazole that can be taken by allowing the ...

Endo’s Par unit is offering dexlansoprazole 30 mg capsules, which is the generic of Takeda's Dexilant. This additional dosage strength rounds out the product family, now with both 30 mg and 60 mg ...

DEERFIELD, IL, USA I January 27, 2016 I Takeda Pharmaceuticals U.S.A., Inc., (Takeda) (TSE: 4502) today announced that the United States (U.S.) Food and Drug Administration (FDA) approved Dexilant ...

Takeda announced that the Food and Drug Administration (FDA) has approved Dexilant (dexlansoprazole) delayed-release capsules and Dexilant SoluTab delayed-release orally-disintegrating tablets for ...

Please provide your email address to receive an email when new articles are posted on . Takeda has announced that the FDA approved its Dexilant SoluTab delayed-release formulation of the proton pump ...

DEERFIELD, Ill. A renamed product for gastroesophageal reflux disease is on the shelves of U.S. pharmacies, manufacturer Takeda Pharmaceuticals North America said Monday. Takeda announced the ...

March 4, 2010 — The brand name of the heartburn drug dexlansoprazole (Kapidex, Takeda Pharmaceuticals North America Inc) has been changed to Dexilant, the US Food and Drug Administration (FDA) ...

TAIPEI, April 27, 2015 /PRNewswire/ -- TWi Pharmaceuticals, Inc. ("TWi") today announced that it has entered into a Settlement Agreement with Takeda Pharmaceutical Company Limited, Takeda ...

Takeda Pharmaceuticals announced that Kapidex (dexlansoprazole delayed-release capsules) will now be marketed under a new product trade name, Dexilant, due to reports of dispensing errors. Takeda and ...